Ainos, Inc. Files 8-K Report

Ticker: AIMDW · Form: 8-K · Filed: Aug 7, 2025 · CIK: 1014763

Ainos, INC. 8-K Filing Summary
FieldDetail
CompanyAinos, INC. (AIMDW)
Form Type8-K
Filed DateAug 7, 2025
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.01, $2.1 million
Sentimentneutral

Sentiment: neutral

Topics: 8-K, reporting

Related Tickers: AIMD

TL;DR

Ainos (AIMD) filed a routine 8-K, no major news.

AI Summary

On August 6, 2025, Ainos, Inc. filed an 8-K report detailing other events and financial statements. The company, formerly known as Amarillo Biosciences Inc., is incorporated in Texas and headquartered in San Diego, California. This filing does not appear to disclose specific financial transactions or material events beyond the standard reporting requirements.

Why It Matters

This 8-K filing indicates Ainos, Inc. is fulfilling its reporting obligations with the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not appear to contain any new material information that would significantly alter the company's risk profile.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Ainos, Inc.?

The filing is a Current Report on Form 8-K, used to announce material events that occur between quarterly filings, and it also includes financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on August 6, 2025.

What was Ainos, Inc. formerly known as?

Ainos, Inc. was formerly known as Amarillo Biosciences Inc.

In which state is Ainos, Inc. incorporated?

Ainos, Inc. is incorporated in Texas.

What is the business address and phone number provided for Ainos, Inc.?

The business address is 8880 Rio San Diego Drive, Ste. 800, San Diego, CA 92108, and the telephone number is (858) 869-2986.

Filing Stats: 445 words · 2 min read · ~1 pages · Grade level 9.6 · Accepted 2025-08-07 08:17:03

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ainos, Inc. Date: August 7, 2025 By: /s/ Chun-Hsien Tsai Name: Chun-Hsien Tsai Title: Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing